Oncogene - Table of Contents alert Volume 31 Issue 27

TABLE OF CONTENTS Volume 31, Issue 27 (July 2012) In this issue Original Articles Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogene has an Impact Factor of 6.373 (Journal Citation Report 2011) Thank you to all our authors, readers, editors, and reviewers for their contributions and support.   Original Articles Top Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia E J Gallagher, Y Fierz, A Vijayakumar, N Haddad, S Yakar and D LeRoith Oncogene 2012 31: 3213-3222; advance online publication, October 31, 2011; 10.1038/onc.2011.495 Abstract | Full Text Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α F Vesuna, A Lisok, B Kimble, J Domek, Y Kato, P van der Groep, D Artemov, J Kowalski, H Carraway, P van Diest and V Raman Oncogene 2012 31: 3223-3234; advance online publication, November 7, 2011; 10.1038/onc.2011.483 Abstract | Full Text RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival V Goidts, J Bageritz, L Puccio, S Nakata, M Zapatka, S Barbus, G Toedt, B Campos, A Korshunov, S Momma, E Van Schaftingen, G Reifenberger, C Herold-Mende, P Lichter and B Radlwimmer Oncogene 2012 31: 3235-3243; advance online publication, November 7, 2011; 10.1038/onc.2011.490 Abstract | Full Text Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability R B Slee, C M Steiner, B-S Herbert, G H Vance, R J Hickey, T Schwarz, S Christan, M Radovich, B P Schneider, D Schindelhauer and B R Grimes Oncogene 2012 31: 3244-3253; advance online publication, November 28, 2011; 10.1038/onc.2011.502 Abstract | Full Text The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy H Kidoya, N Kunii, H Naito, F Muramatsu, Y Okamoto, T Nakayama and N Takakura Oncogene 2012 31: 3254-3264; advance online publication, October 31, 2011; 10.1038/onc.2011.489 Abstract | Full Text The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53 S-O Lee, T Andey, U-H Jin, K Kim, M Sachdeva and S Safe Oncogene 2012 31: 3265-3276; advance online publication, November 14, 2011; 10.1038/onc.2011.504 Abstract | Full Text p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors S Fransson, A Uv, H Eriksson, M K Andersson, Y Wettergren, M Bergo and K Ejeskär Oncogene 2012 31: 3277-3286; advance online publication, October 24, 2011; 10.1038/onc.2011.492 Abstract | Full Text Loss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK–JMJD3–p16INK4a signaling axis T-Y Lin, Y-C Cheng, H-C Yang, W-C Lin, C-C Wang, P-L Lai and S-Y Shieh Oncogene 2012 31: 3287-3297; advance online publication, October 24, 2011; 10.1038/onc.2011.491 Abstract | Full Text Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature S E Franks, C I Campbell, E F Barnett, M D Siwicky, J Livingstone, S Cory and R A Moorehead Oncogene 2012 31: 3298-3309; advance online publication, October 24, 2011; 10.1038/onc.2011.486 Abstract | Full Text Corrigendum Top The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53 S-O Lee, T Andey, U-H Jin, K Kim, M Singh and S Safe Oncogene 2012 31: 3310; 10.1038/onc.2012.184 Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.